The global home infusion therapy market is projected to reach USD 44.98 billion by 2028, growing at a CAGR of 7.6%. Inclination towards home health care, growing hospital-acquired infections and rising number of enduring diseases is driving the global home infusion therapy market.
Adroit Market Research report on global home infusion therapy market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global home infusion therapy market have been studied in detail.
The gathering and consumption of data in health care has been a sluggish process ever since electronic health records first seemed in the 1970s. Nowadays, the practice of data understandings is rushing at a terrific pace which it has transformed many markets including the home care serving to lead the way. Old infusion therapies classically treat shorter-term or acute patient disorders, whereas specialty infusion therapies are usually more costly, entail high value services, and are longer-term drug therapies treating patients’ chronic conditions.
The global home infusion therapy market is categorized based on product and application. On the basis of product, the market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The infusion pumps segment dominated the market in 2019, while the needleless connectors is expected to grow at a highest CAGR over the forecast period.
North America dominated the market for home infusion therapy in 2019, while Asia Pacific is anticipated to grow at a highest CAGR owing to growing occurrence of diabetes. Key players of the global home infusion therapy market include B. Braun Melsungen, Fresenius Kabi, Baxter, Becton, Dickinson & Company, Smiths Medical, Eli Lilly & Company, Terumo Corporation, Caesarea Medical Electronics, ICU Medical, CareFusion Corporation among others.
Key segments of the global home infusion therapy market
Product Overview, 2018-2028 (USD Billion)
- Infusion Pumps
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
Application Overview, 2018-2028 (USD Billion)
- Hydration Therapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
Regional Overview, 2018-2028 (USD Billion)
- North America
- United Kingdom
- Asia Pacific
- South America
- Middle East & Africa
- South Africa